PETKANAS DEAN 4
4 · NEUROPATHIX, INC. · Filed Mar 16, 2021
Insider Transaction Report
Form 4
PETKANAS DEAN
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2021-03-12$0.13/sh+192,308$25,000→ 23,594,432 total(indirect: See Note) - Award
Common Stock
2021-03-12$0.13/sh+692,308$90,000→ 22,984,029 total(indirect: See Note) - Award
Employee Stock Option
2021-03-12+1,450,000→ 1,450,000 totalExercise: $0.13Exp: 2031-03-11→ Common Stock (1,450,000 underlying)
Footnotes (4)
- [F1]The reporting person agreed to accept 692,308 restricted shares of the issuers common stock in exchange for the discharge of an aggregate of $90,000 of accrued but unpaid monies payable by the issuer to the reporting person as a portion of his salary. The issuance was approved by the issuers board of directors on March 12, 2021. The price of the shares acquired by the reporting person is equal to the closing price of the Companys common stock on March 11, 2021, which was $0.13.
- [F2]Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
- [F3]Golden Gate Capital Partners, LLC agreed to accept 192,308 restricted shares of the issuer's common stock in exchange for the discharge of an aggregate of $25,000 of accrued but unpaid corporate expenses payable by the issuer to Golden Gate Capital Partners, LLC. The issuance was approved by the issuer's board of directors on March 12, 2021. The price of the shares acquired by Golden Gate Capital Partners, LLC is equal to the closing price of the Company's common stock on March 11, 2021, which was $0.13.
- [F4]1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter.